Jil Alexandra Schrader

4PUBLICATIONS
16CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 19, 2024
The tyrosine kinase Yes1 is a druggable host factor of HEV.

Jil Alexandra Haase, Abarna Baheerathan, Xin Zhang

|May 10, 2024
Targeting cellular cathepsins inhibits hepatitis E virus entry.

Mara Klöhn, Thomas Burkard, Juliana Janzen

|Feb 06, 2023
EGF receptor modulates HEV entry in human hepatocytes.

Jil A Schrader, Thomas L Burkard, Yannick Brüggemann

|Nov 27, 2021
Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma.

Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann

Pageof 1